Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy (NeuroPredict)

NCT05546138 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT05546138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05546138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy (NeuroPredict)
Lead sponsor
Aalborg University Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2023
Completion date
December 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathy, diabetic, small nerve fiber neuropathy, type 1 diabetes